Understanding and Targeting the DNA Repair Network in Cancer
了解和靶向癌症中的 DNA 修复网络
基本信息
- 批准号:8587577
- 负责人:
- 金额:$ 23.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-18 至 2016-01-31
- 项目状态:已结题
- 来源:
- 关键词:BRCA1 geneBRCA2 geneBindingBiochemicalCaenorhabditis elegansCell NucleusCellsCharacteristicsChromosome SegregationComplexCore ProteinCytoplasmDNA DamageDNA Double Strand BreakDNA RepairDNA lesionDNA repair proteinDataDefense MechanismsDevelopmentDiagnosisDouble Strand Break RepairDrosophila genusEnsureEtiologyFoundationsFunctional disorderGene SilencingGeneticGenomeGenomic InstabilityGenomicsGenotoxic StressGoalsHeterochromatinHumanKnowledgeLeadLesionLightMaintenanceMalignant NeoplasmsMediatingMessenger RNAMicroRNAsMolecularMutationNuclearOrganismPathway interactionsPhosphorylationPhosphotransferasesPlayPost-Translational Protein ProcessingPredispositionProcessProteinsProteomicsPublishingRNARNA Interference PathwayRecruitment ActivityResearchRoleSiteSmall Interfering RNASmall RNAStimulusTestingTranslatingTranslational Repressionbasecancer cellcancer preventioncancer riskcareerchromatin remodelingclinical applicationhomologous recombinationimprovedinhibitor/antagonistinsightnovelnovel strategiesplant fungipreventprogramsprotein protein interactionpublic health relevancerecombinational repairrepairedresponsetranslational studytransmission processtumortumorigenesis
项目摘要
UNDERSTANDING AND TARGETING THE DNA REPAIR NETWORK IN CANCER
DESCRIPTION: Genomic instability is a characteristic of cancer cells. Homologous
recombination (HR)-mediated DNA repair represents an error-free repairing mechanism to
maintain genomic integrity and ensure high-fidelity transmission of genetic information. My
long-term goal is to establish a successful and sustainable independent research program
with a core competency in the study of HR repair using genomic and proteomic
approaches. In my independent career, I wish to pursue (1) fundamental studies to
understand HR-mediated DNA repair and its dysfunction in tumorigenesis and (2)
mechanism-based translational studies to translate fundamental breakthroughs in HR
repair into clinical applications in cancer prevention, diagnosis, prognostication, and
therapy.
The overall objective of my proposed research, which will lay the foundation for my
independent research career, is to understand the novel nuclear function of human Ago2,
a core protein in RNA interference pathways, in HR repair and genome maintenance.
Based on my preliminary data, I hypothesize that in the context of DNA damage response,
via fine-tuned regulatory mechanisms by posttranslational modifications, potentially
through ATM/ATR kinase-dependent phosphorylation, human nuclear Ago2 regulates HR
repair of double-strand breaks by recruiting DNA repair proteins at damage sites via
protein-protein interactions. I will test this hypothesis by pursuing 3 specific aims through
an integrated platform that combines mechanistic and functional studies: (1) Determine
the function of Ago2 as a novel regulator in HR repair. (2) Characterize posttranslational
modifications of Ago2 induced by DNA damage in HR repair. (3) Determine the nuclear
function of Ago2 in preventing genomic instability and tumorigenesis. The proposed
research is significant because it challenges the current research paradigm that human
Ago2 functions predominantly in the cytoplasm. This study will shed light on how 2
evolutionarily conserved genome defense mechanisms, the small regulatory RNA
pathways and DNA damage response pathway, converge at DNA lesions in the process
of HR repair via the functional involvement of Ago2 protein.
肿瘤DNA修复网络的研究进展
描述:基因组不稳定性是癌细胞的一个特征。同源
重组(HR)介导的DNA修复代表了一种无错误的修复机制,
保持基因组的完整性,确保遗传信息的高保真传输。我
长期目标是建立一个成功的和可持续的独立研究计划
在使用基因组和蛋白质组学研究HR修复方面具有核心竞争力
接近。在我独立的职业生涯中,我希望从事(1)基础研究,
了解HR介导的DNA修复及其在肿瘤发生中的功能障碍;(2)
以机制为基础的转化研究,转化人力资源的根本突破
在癌症预防、诊断、诊断和治疗中的临床应用,
疗法
我提出的研究的总体目标,这将奠定基础,我
独立的研究生涯,是为了了解人类Ago 2的新的核功能,
RNA干扰途径、HR修复和基因组维持中的核心蛋白。
根据我的初步数据,我假设在DNA损伤反应的背景下,
通过翻译后修饰的微调调节机制,
通过ATM/ATR激酶依赖的磷酸化,人核Ago 2调节HR
通过在损伤位点募集DNA修复蛋白来修复双链断裂,
蛋白质相互作用我将通过追求3个具体目标来测试这个假设,
一个结合了机理和功能研究的综合平台:(1)确定
Ago 2作为一种新的调节剂在HR修复中的功能。(2)翻译后表征
在HR修复中由DNA损伤诱导的Ago 2修饰。(3)确定核
Ago 2在防止基因组不稳定性和肿瘤发生中的功能。拟议
研究是重要的,因为它挑战了目前的研究范式,人类
Ago 2主要在细胞质中发挥作用。这项研究将揭示如何2
进化上保守的基因组防御机制,小调控RNA
途径和DNA损伤反应途径,在DNA损伤的过程中会聚
通过Ago 2蛋白的功能参与HR修复。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Guang Peng其他文献
Guang Peng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Guang Peng', 18)}}的其他基金
Mechanisms of radioresistance and strategies for radiosensitization in ovarian clear cell carcinoma
卵巢透明细胞癌的放射抵抗机制及放射增敏策略
- 批准号:
10446186 - 财政年份:2016
- 资助金额:
$ 23.41万 - 项目类别:
Mechanisms of radioresistance and strategies for radiosensitization in OCCC
OCCC 的放射抵抗机制和放射增敏策略
- 批准号:
10218064 - 财政年份:2016
- 资助金额:
$ 23.41万 - 项目类别:
Mechanisms of radioresistance and strategies for radiosensitization in OCCC
OCCC 的放射抵抗机制和放射增敏策略
- 批准号:
9564069 - 财政年份:2016
- 资助金额:
$ 23.41万 - 项目类别:
Mechanisms of radioresistance and strategies for radiosensitization in ovarian clear cell carcinoma
卵巢透明细胞癌的放射抵抗机制及放射增敏策略
- 批准号:
10684787 - 财政年份:2016
- 资助金额:
$ 23.41万 - 项目类别:
Mechanisms of radioresistance and strategies for radiosensitization in OCCC
OCCC 的放射抵抗机制和放射增敏策略
- 批准号:
9763331 - 财政年份:2016
- 资助金额:
$ 23.41万 - 项目类别:
Understanding and Targeting the DNA Repair Network in Cancer
了解和靶向癌症中的 DNA 修复网络
- 批准号:
8795698 - 财政年份:2011
- 资助金额:
$ 23.41万 - 项目类别:
Understanding and Targeting the DNA Repair Network in Cancer
了解和靶向癌症中的 DNA 修复网络
- 批准号:
8046568 - 财政年份:2011
- 资助金额:
$ 23.41万 - 项目类别:
Understanding and Targeting the DNA Repair Network in Cancer
了解和靶向癌症中的 DNA 修复网络
- 批准号:
8303240 - 财政年份:2011
- 资助金额:
$ 23.41万 - 项目类别:
Understanding and Targeting the DNA Repair Network in Cancer
了解和靶向癌症中的 DNA 修复网络
- 批准号:
8618778 - 财政年份:2011
- 资助金额:
$ 23.41万 - 项目类别:
相似海外基金
The role of the BRCA1 and BRCA2 gene in the pathogenesis
BRCA1和BRCA2基因在发病机制中的作用
- 批准号:
7315995 - 财政年份:
- 资助金额:
$ 23.41万 - 项目类别:
BRCA1 and BRCA2 gene in breast cancer pathogenesis
BRCA1和BRCA2基因在乳腺癌发病机制中的作用
- 批准号:
6988627 - 财政年份:
- 资助金额:
$ 23.41万 - 项目类别:
The role of the BRCA1 and BRCA2 gene in the pathogenesis
BRCA1和BRCA2基因在发病机制中的作用
- 批准号:
6830360 - 财政年份:
- 资助金额:
$ 23.41万 - 项目类别:
The role of the BRCA1 and BRCA2 gene in the pathogenesis of breast cancer
BRCA1和BRCA2基因在乳腺癌发病机制中的作用
- 批准号:
7594304 - 财政年份:
- 资助金额:
$ 23.41万 - 项目类别:
The role of the BRCA1 and BRCA2 gene in the pathogenesis of breast cancer
BRCA1和BRCA2基因在乳腺癌发病机制中的作用
- 批准号:
10020051 - 财政年份:
- 资助金额:
$ 23.41万 - 项目类别:
The role of the BRCA1 and BRCA2 gene in the pathogenesis of breast cancer
BRCA1和BRCA2基因在乳腺癌发病机制中的作用
- 批准号:
9152707 - 财政年份:
- 资助金额:
$ 23.41万 - 项目类别:
Role of BRCA1/BRCA2 gene in pathogenesis of breat cancer
BRCA1/BRCA2基因在乳腺癌发病机制中的作用
- 批准号:
6556003 - 财政年份:
- 资助金额:
$ 23.41万 - 项目类别:
The role of the BRCA1 and BRCA2 gene in the pathogenesis of breast cancer
BRCA1和BRCA2基因在乳腺癌发病机制中的作用
- 批准号:
8349977 - 财政年份:
- 资助金额:
$ 23.41万 - 项目类别:
The role of the BRCA1 and BRCA2 gene in the pathogenesis of breast cancer
BRCA1和BRCA2基因在乳腺癌发病机制中的作用
- 批准号:
7734867 - 财政年份:
- 资助金额:
$ 23.41万 - 项目类别:
The role of the BRCA1 and BRCA2 gene in the pathogenesis of breast cancer
BRCA1和BRCA2基因在乳腺癌发病机制中的作用
- 批准号:
8750661 - 财政年份:
- 资助金额:
$ 23.41万 - 项目类别:














{{item.name}}会员




